广州伟伯科技有限公司
您的位置:首页 > 产品中心 > 211427-08-6, Diquafosol tetrasodium
产品搜索:

Diquafosol tetrasodium

产品编号:4086105
规格:>95% (HPLC)
CAS NO:211427-08-6
包装规格:5 MG,25 MG
产品类别:进口试剂
品牌:Sigma-Aldrich
优惠价:立即咨询
产品价格
产品编号包装单位单价(元)国内现货国外库存询价单
40861055 MG897
408610525 MG3940
产品别名

211427-08-6

Diquafosol tetrasodium

Diuridine 5′-tetraphosphate, sodium salt

KPY 998

Diuridine 5′-tetraphosphate

Up4U tetrasodium

INS365

P ,P -Diuridine 5′-tetraphosphate tetrasodium salt

Uridine 5′-(pentahydrogen tetraphosphate), P′′′→5′-ester with uridine, sodium salt (1:4)

Up4U 4Na

结构式
基本信息
Empirical Formula【经验(实验)分子式】
C18H22N4Na4O23P4
Molecular weight
878.23
Biochem/physiol Actions【生化/生理作用】
Diquafosol (Up4U, INS365) is a selective purinergic receptor P2Y2 agonist (EC50 = 100 nM/P2Y2, 400 nM/P2Y4, 20 μM/P2Y6, >100 μM/P2Y1 by calcium mobilization using respective 1321N P2Y subtype transfectants). In addition to its in vivo efficacy in anmial dry eye models, diquafosol is also shown to enhance mucociliary clearance in sheep and stimulate vaginal moisture in ovariectomized rabbits.
P2Y2/P2Y4 purinoceptor agonist: EC50 = 0.10 μM at P2Y2, 0.4 μM at P2Y4 (20 μM at P2Y6) in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y1, P2Y2, P2Y4 and P2Y6
Diagnostic Implications【诊断含义】
In clinical development for the treatment of dry eye and chronic lung disease, such as cystic fibrosis
产品性质
Quality Level【质量水平】
100
Assay【测定】
>95% (HPLC)
form【形式】
powder
optical activity【旋光性】
[α]/D -12.0 to -8.0°, c = 1.0 in H2O
color【颜色】
white to beige
solubility【溶解性】
H2O: 2 mg/mL, clear
storage temp.【储存温度】
−20℃
安全信息
Storage Class Code【储存分类代码】
11 - Combustible Solids
WGK
WGK 3
广州伟伯科技有限公司 版权所有 CopyRight ©2006-2024, All Rights Reserved
工信部备案号:粤ICP备08114744号   Page Run Time: 0.0081